Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. That said, here are three stocks where Wall Street’s estimates seem disconnected from reality and some better opportunities to consider.

Consensus Price Target: $50.60 (38.9% implied return)

Founded by two brothers from Texas, YETI (NYSE:YETI) specializes in durable outdoor goods including coolers, drinkware, and other gear tailored to adventure enthusiasts.

Why Should You Sell YETI?

Sales trends were unexciting over the last five years as its 11.3% annual growth was below the typical consumer discretionary company

Free cash flow margin is expected to remain in place over the coming year

Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

YETI is trading at $36.42 per share, or 12.9x forward P/E. Read our free research report to see why you should think twice about including YETI in your portfolio, it’s free.

Consensus Price Target: $398.90 (24.2% implied return)

Pivoting its business model after realizing there was more success in delivering produce than selling it, Saia (NASDAQ:SAIA) is a provider of freight transportation solutions.

Why Are We Cautious About SAIA?

Disappointing tons shipped over the past two years imply it may need to invest in improvements to get back on track

Low free cash flow margin of -0.4% declined over the last five years as its investments ramped, giving it little breathing room

Waning returns on capital imply its previous profit engines are losing steam

Saia’s stock price of $321.12 implies a valuation ratio of 30.5x forward P/E. If you’re considering SAIA for your portfolio, see our FREE research report to learn more.

Consensus Price Target: $31.85 (46.3% implied return)

Operating in 13 states and the District of Columbia with over 4,300 providers serving more than 4.8 million patients, Privia Health (NASDAQ:PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models.

Why Are We Wary of PRVA?

Subscale operations are evident in its revenue base of $2.12 billion, meaning it has fewer distribution channels than its larger rivals

Negative returns on capital show that some of its growth strategies have backfired

At $21.77 per share, Privia Health trades at 19.6x forward P/E. Dive into our free research report to see why there are better opportunities than PRVA.

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.